Angel M. Lora-Garcia

Av. De Las Fuerzas Armadas 2
Granada, AN 18014, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

MHC heterogeneity and response of metastases to immunotherapy.

MHC heterogeneity and response of metastases to immunotherapy.

Journal: Cancer metastasis reviews

Published: November 14, 2020

Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic Vaccine.

Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic Vaccine.

Journal: Cancers

Published: April 05, 2020

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy.

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy.

Journal: Frontiers in immunology

Published: October 14, 2017

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab.

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab.

Journal: Frontiers in pharmacology

Published: April 20, 2017

The urgent need to recover MHC class I in cancers for effective immunotherapy.

The urgent need to recover MHC class I in cancers for effective immunotherapy.

Journal: Current opinion in immunology

Published: October 28, 2015

Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.

Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.

Journal: Cancer research

Published: November 21, 2014

Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype.

Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype.

Journal: International journal of cancer

Published: August 01, 2014

Class II transactivator-induced MHC class II expression in pancreatic cancer cells leads to tumor rejection and a specific antitumor memory response.

Class II transactivator-induced MHC class II expression in pancreatic cancer cells leads to tumor rejection and a specific antitumor memory response.

Journal: Pancreas

Published: July 03, 2014

The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity.

The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: February 19, 2014

T lymphocytes restrain spontaneous metastases in permanent dormancy.

T lymphocytes restrain spontaneous metastases in permanent dormancy.

Journal: Cancer research

Published: February 18, 2014

Effect of thyroid hormone-nitric oxide interaction on tumor growth, angiogenesis, and aminopeptidase activity in mice.

Effect of thyroid hormone-nitric oxide interaction on tumor growth, angiogenesis, and aminopeptidase activity in mice.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: November 18, 2013

Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.

Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.

Journal: Oncogene

Published: March 06, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026